Absci Corporation (ABSI)
NASDAQ: ABSI · IEX Real-Time Price · USD
3.970
-0.140 (-3.41%)
At close: Jul 19, 2024, 4:00 PM
4.000
+0.030 (0.76%)
Pre-market: Jul 22, 2024, 9:00 AM EDT
Absci Employees
Absci had 155 employees as of December 31, 2023. The number of employees decreased by 38 or -19.69% compared to the previous year.
Employees
155
Change (1Y)
-38
Growth (1Y)
-19.69%
Revenue / Employee
$34,497
Profits / Employee
-$704,426
Market Cap
448.94M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 155 | -38 | -19.69% |
| Dec 31, 2022 | 193 | -19 | -8.96% |
| Dec 31, 2021 | 212 | 110 | 107.84% |
| Dec 31, 2020 | 102 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bioventus | 970 |
| Pacific Biosciences of California | 796 |
| Nano-X Imaging | 164 |
| Voyager Therapeutics | 162 |
| Nkarta | 150 |
| MaxCyte | 143 |
| EyePoint Pharmaceuticals | 121 |
| Kyverna Therapeutics | 96 |
ABSI News
- 12 days ago - Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024 - GlobeNewsWire
- 18 days ago - Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results - GlobeNewsWire
- 4 months ago - Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results - GlobeNewsWire
- 5 months ago - Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 5 months ago - Absci Announces Pricing of Public Offering of Common Stock - GlobeNewsWire
- 5 months ago - Absci Announces Proposed Public Offering of Common Stock - GlobeNewsWire